.png)
We are developing AI for safer cell therapies.
Through generative design and functional prediction of regulatory DNA, we create synthetic switches and dials that program gene expression with unprecedented precision.
Our team of engineers and biologists comes from leading institutions including NVIDIA, Berkeley, Duke, Dartmouth, and UIUC. The scientific advisory board consists of Dr. Manolis Kellis, Dr. Nicole Paulk and Dr. Rashid Bashir. We are backed by Y Combinator and top investors from Silicon Valley and Boston.